Tropomyosin  Alpha Polyclonal Antibody

TPM1 is a member of the tropomyosin family of highly conserved, widely distributed actin-binding proteins involved in the contractile system of striated and smooth muscles and the cytoskeleton of non-muscle cells. Tropomyosin is composed of two alpha-helical chains arranged as a coiled-coil. It is polymerized end to end along the two grooves of actin filaments and provides stability to the filaments. The tropomyosin alpha-1 chain is one type of alpha helical chain that forms the predominant tropomyosin of striated muscle, where it also functions in association with the troponin complex to regulate the calcium-dependent interaction of actin and myosin during muscle contraction. In smooth muscle and non-muscle cells, alternatively spliced transcript variants encoding a range of isoforms have been described. Mutations in this gene are associated with type 3 familial hypertrophic cardiomyopathy.

The Tropomyosin Alpha Polyclonal Antibody is a highly specific and sensitive immunological tool designed for the detection and quantification of Tropomyosin Alpha protein in various biological samples. This antibody has been meticulously developed using advanced techniques to ensure exceptional performance and reliability.

Tropomyosin Alpha is a crucial protein involved in the regulation of actin-myosin interactions, playing a pivotal role in muscle contraction and cell motility. Its aberrant expression or dysfunction has been implicated in various pathological conditions, including cancer and cardiovascular diseases. Therefore, the accurate measurement of Tropomyosin Alpha levels is of utmost importance in both research and clinical settings.

The Tropomyosin Alpha Polyclonal Antibody exhibits high affinity and specificity towards its target protein, enabling precise and reproducible results. It has been extensively validated through rigorous testing, ensuring minimal cross-reactivity with other related proteins. This antibody demonstrates exceptional sensitivity, allowing for the detection of even low levels of Tropomyosin Alpha in complex biological matrices.

Furthermore, the Tropomyosin Alpha Polyclonal Antibody is compatible with a wide range of experimental techniques, including Western blotting, immunohistochemistry, and immunofluorescence. Its versatility and ease of use make it an ideal choice for various applications, such as protein expression profiling, biomarker discovery, and disease diagnosis.

In summary, the Tropomyosin Alpha Polyclonal Antibody is a reliable and efficient tool for the accurate detection and quantification of Tropomyosin Alpha protein. Its exceptional sensitivity, specificity, and compatibility with multiple experimental techniques make it an invaluable asset for researchers and clinicians alike. Trust in this antibody to enhance your scientific investigations and contribute to advancements in the understanding and treatment of Tropomyosin Alpha-related disorders.